Journal Home
Search for

Articles in Press

Return to articles in press list

Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women

A. Lapointea, A. Tchernofb, B. Lamarchea, M.E. Pichéa, J. Weisnagelcd, J. Bergerond, S. LemieuxadCorresponding Author Informationemail address

Received 12 June 2009; received in revised form 16 October 2009; accepted 20 October 2009. published online 15 February 2010.
Corrected Proof

Abstract 

Background and aims

To investigate associations between plasma adiponectin concentration and very-low density lipoprotein–triglyceride (VLDL-TG) secretion and catabolism in postmenopausal women.

Methods and results

This cross-sectional study included 30 postmenopausal women. Plasma adiponectin concentration was measured by ELISA. Insulin sensitivity was assessed by a 2-h euglycemic-hyperinsulinemic clamp. Fasting plasma glucose (FPG) and 2-hour plasma glucose (2hPG) were measured during an oral glucose tolerance test. The calculation of VLDL-TG fractional catabolic rate (FCR) and VLDL-TG total secretion rate (TSR) were based on the monoexponential decrease of TG-[2H5] glycerol values obtained following the administration of a 2H5-glycerol bolus. Plasma adiponectin concentration was negatively associated with VLDL-TG TSR (r=−0.50; p=0.005) and positively associated with VLDL-TG FCR (r=0.54; p<0.002). This latter association remained significant after further adjustments for insulin sensitivity, visceral adipose tissue, HDL-C, FPG and 2hPG concentrations. In a multivariate model including adiponectin, insulin sensitivity and 2hPG, plasma adiponectin level was the strongest correlate of VLDL-TG FCR.

Conclusions

Elevated plasma adiponectin concentration is associated with a favourable VLDL-TG metabolism.

a Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada

b Molecular Endocrinology and Oncology Research Center, CHUQ, Laval University, Québec, Canada

c Diabetes Research Unit, CHUQ, Laval University, Québec, Canada

d Lipid Research Center, CHUQ, Laval University, Québec, Canada

Corresponding Author InformationCorresponding author. Institute of Nutraceuticals and Functional Foods, Laval University, 2440 Hochelaga Blvd, Québec G1V 0A6, Canada. Tel.: +1 418 656 2131x3637; fax: +1 418 656 5877.

PII: S0939-4753(09)00253-1

doi:10.1016/j.numecd.2009.10.007